推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

CANCER LETTERS 期刊收藏夹

欢迎您加入月均活跃用户100万+的科研社区!如您有任何系统建议,请点此反馈;如有合作推广需求,请点此洽谈

按期刊名首写字母查看 CANCER LETT最新评论:审稿速度:2.0 | 投稿命中率:95.0经验分享:还有朋友是一样的吗,杂志接受了,支付了版面费,然后又被拒稿,而且没有明确原因拒稿... (2025-05-21)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
近期推荐:
SCI论文AI润色+人工QC服务
同行专家帮助选刊
Springer Nature特刊征稿
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


CANCER LETTERS期刊基本信息Hello,您是该期刊的第358651位访客


基本信息 登录收藏
期刊名字CANCER LETTERSCANCER LETTERS

CANCER LETT
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
9.0
64人评分
我要评分

声誉
9.8

影响力
8.3

速度
9.2

期刊ISSN0304-3835
蝌蝌APP,让您与同行交流更轻松
立即下载
E-ISSN1872-7980
2024-2025最新影响因子
(数据来源于搜索引擎)
10.1 点击查看影响因子趋势图
实时影响因子 截止2025年5月19日:10.033
2024-2025自引率16.80%点击查看自引率趋势图
五年影响因子9.5
JCI期刊引文指标 2.26
h-index 161
CiteScore
2025年最新版
CiteScoreSJRSNIPCiteScore排名
13.902.7561.544
学科分区排名百分位
大类:Medicine
小类:Oncology
Q138 / 415
大类:Medicine
小类:Cancer Research
Q131 / 233

期刊简介
CANCER LETTERS is a journal providing rapid publication of full-length articles in the broad area of cancer research. The journal places emphasis on the molecular and cell biology of cancer, oncogenes, carcinogenesis, radiation biology, molecular pathology, hormones and cancer, viral oncology, biology of cancer and metastasis, molecular cytogenetics, epidemiology; and experimental therapeutics. The primary criterion for publication is interest to a multidisciplinary audience. Papers should be technically sound and substantiated by sufficient experimental detail. Clinical papers will be accepted if they contribute to the understanding of the basic mechanisms underlying disease.
期刊官方网站https://www.journals.elsevier.com/cancer-letters
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板由LetPub整理,仅供参考。开通VIP可免费下载,并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
期刊投稿网址https://www.editorialmanager.com/CANLET
期刊语言要求Language
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CANCER LETTERS的语言要求,还能让CANCER LETTERS编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CANCER LETTERS编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(1篇) 论文致谢(6篇)
提交文稿
是否OA开放访问No
通讯方式ELSEVIER IRELAND LTD, ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, IRELAND, 00000
出版商Elsevier Ireland Ltd
涉及的研究方向医学-肿瘤学
出版国家或地区NETHERLANDS
出版语言English
出版周期Biweekly
出版年份1975
年文章数 560点击查看年文章数趋势图
Gold OA文章占比29.33%
研究类文章占比:
文章 ÷(文章 + 综述)
90.89%
WOS期刊SCI分区
2024-2025年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ130/326
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ125/326
中国科学院《国际期刊预警
名单(试行)》名单
2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2025年3月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区1区4区
ONCOLOGY
肿瘤学
1区2区2区
中国科学院SCI期刊分区
2023年12月升级版
大类学科小类学科Top期刊综述期刊
医学 2区1区1区
ONCOLOGY
肿瘤学
2区4区2区
中国科学院SCI期刊分区
2022年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区1区3区
ONCOLOGY
肿瘤学
1区4区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0304-3835%5BISSN%5D
平均审稿速度网友分享经验:
平均2.7个月
来源Elsevier官网:
平均3.3周
平均录用比例网友分享经验:
约52.27%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在CANCER LETTERS顺利发表。
快看看作者怎么说吧:服务好评(1篇) 论文致谢(6篇)
提交文稿
在线出版周期来源Elsevier官网:
平均8.3周
期刊常用信息链接
同领域相关期刊 CANCER LETTERS期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CANCER LETTERS中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CANCER LETTERS上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    Nature Reviews Clinical Oncology127114.50
    NATURE REVIEWS CANCER396103.80
    ANNALS OF ONCOLOGY21070.40
    CANCER CELL29557.70
    JOURNAL OF CLINICAL ONCOLOGY49438.90
    LANCET ONCOLOGY27450.80
    CANCER RESEARCH41117.80
    SEMINARS IN CANCER BIOLOGY13435.00
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH6720.20
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE743141
    BIOMATERIALS615476
    BIOMEDICINE & PHARMACOTHERAPY608713
    Frontiers in Pharmacology575372
    COMPUTERS IN BIOLOGY AND MEDICINE571202
    JOURNAL OF ETHNOPHARMACOLOGY566093
    Frontiers in Immunology563026
    Frontiers in Oncology503977
    COLLOIDS AND SURFACES B-BIOINTERFACES471655
    PHYTOMEDICINE468326
  •  

    CANCER LETTERS CANCER LETTERS
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Metabolic reprogramming in cholangiocarcinoma cancer stem cells: Emerging therapeutic paradigms

    Author: Wang, Qi; Long, Tanqing; Tang, Peijuan; Xu, Chuanrui; Wang, Liang; Liu, Juan
    Journal: CANCER LETTERS. 2025; Vol. 622, Issue , pp. -. DOI: 10.1016/j.canlet.2025.217714
        PubMed      DOI
    2.CD44 identified as a diagnostic biomarker for highly malignant CA19-9 negative pancreatic cancer

    Author: Tang, Jiatong; Li, Xiaoyang; Tang, Neng; Lin, Xiawen; Du, Yixiang; Zhang, Shuo; Li, Qi; Zhang, Yifan; Zhang, Yixuan; Hang, Hexing; Qiu, Tongtong; Qiu, Yudong; Cheng, Hao; Dai, Zhan; Hong, Hao; Wei, Wei; He, Jian; Yan, Chao
    Journal: CANCER LETTERS. 2025; Vol. 622, Issue , pp. -. DOI: 10.1016/j.canlet.2025.217713
        PubMed      DOI
    3.Allogeneic versus autologous hematopoietic stem cell transplantation for adult T-lymphoblastic lymphoma: A real-world multicenter analysis in China

    Author: Wang, Yuewen; Liu, Weiping; Gu, Zhenyang; Chang, Yu; Zhang, Chunli; Cao, Yang; Lu, Haiyang; Liu, Xiaodan; Lu, Kang; Lu, Jin; Wang, Fengrong; Wang, Luxiang; Yang, Shenmiao; Jiang, Chuanhe; Li, Chuan; Zhang, Mingzhi; Huang, Xiaojun; Zhu, Xiaoyu; Wu, Xiaojin; Hu, Xiaoxia; Mo, Xiaodong; Liu, Daihong
    Journal: CANCER LETTERS. 2025; Vol. 621, Issue , pp. -. DOI: 10.1016/j.canlet.2025.217664
        PubMed      DOI
    4.KAP1 promotes gastric adenocarcinoma progression by activating Hippo/YAP1 signaling via binding to HNRNPAB

    Author: Song, Shumei; Fan, Yibo; Zou, Gengyi; Huo, Longfei; Kumar, Janani; Li, Yuan; Wang, Ruiping; Dai, Enyu; Jin, Jiankang; Scott, Ailing W.; Shao, Shan; Pizzi, Melissa Pool; Vykoukal, Jody V.; Katayama, Hiroyuki; Hanash, Samir; Calin, George A.; Zhang, Xing; Lee, Min Gyu; Wang, Zhenning; Lo, Yuan-Hung; Gan, Qiong; Waters, Rebecca E.; Yin, Feng; Wang, Linghua; Cheng, Xiaodong; Ajani, Jaffer A.; Dhar, Shilpa S.
    Journal: CANCER LETTERS. 2025; Vol. 621, Issue , pp. -. DOI: 10.1016/j.canlet.2025.217695
        PubMed      DOI
    5.Neurturin-induced activation of GFRA2-RET axis potentiates pancreatic cancer glycolysis via phosphorylated hexokinase 2

    Author: Cui, Ran; Wang, Gaoming; Liu, Fuguo; Wang, Yongkun; Zhao, Zinan; Mutailipu, Muladili; Mu, Huiling; Jiang, Xiaohua; Le, Wenjun; Yang, Ludi; Chen, Bo
    Journal: CANCER LETTERS. 2025; Vol. 621, Issue , pp. -. DOI: 10.1016/j.canlet.2025.217583
        PubMed      DOI
    6.Glutathione metabolism in ferroptosis and cancer therapy

    Author: Xue, Xiangfei; Wang, Manyuan; Cui, Jiangtao; Yang, Minying; Ma, Lifang; Kang, Rui; Tang, Daolin; Wang, Jiayi
    Journal: CANCER LETTERS. 2025; Vol. 621, Issue , pp. -. DOI: 10.1016/j.canlet.2025.217697
        PubMed      DOI
    7.Generating research hypotheses to overcome key challenges in the early diagnosis of colorectal cancer-Future application of AI

    Author: Yao, Lan; Yin, Heliang; Yang, Chengyuan; Han, Shuyan; Ma, Jiamin; Graff, J. Carolyn; Wang, Cong-Yi; Jiao, Yan; Ji, Jiafu; Gu, Weikuan; Wang, Gang
    Journal: CANCER LETTERS. 2025; Vol. 620, Issue , pp. -. DOI: 10.1016/j.canlet.2025.217632
        PubMed      DOI
    8.Ferroptosis meets inflammation: A new frontier in cancer therapy

    Author: Liu, Hu; Xue, Hui; Guo, Qian; Xue, Xutong; Yang, Lixue; Zhao, Kaijun; Liu, Yu'e
    Journal: CANCER LETTERS. 2025; Vol. 620, Issue , pp. -. DOI: 10.1016/j.canlet.2025.217696
        PubMed      DOI
    9.The intersections between neuroscience and medulloblastoma

    Author: Wang, Yafei; Yu, Ying; Yu, Jiahua; Wang, Cheng; Wang, Yunkun; Fu, Runxi; Zhang, Chenran
    Journal: CANCER LETTERS. 2025; Vol. 620, Issue , pp. -. DOI: 10.1016/j.canlet.2025.217660
        PubMed      DOI
    10.Apigenin inhibits recurrent bladder cancer progression by targeting VEGF-β

    Author: Shi, Zhen-Duo; Liu, Ying; Tao, Zi-Qi; Chao, Liu; Zhang, Zheng-Guo; Sun, Fang; Yuan, Fu-Kang; Ma, Qing-Fang; Li, Zong-Yun; Chen, Zhe-Sheng; Wu, Shao-Yuan; Han, Cong-Hui
    Journal: CANCER LETTERS. 2025; Vol. 620, Issue , pp. -. DOI: 10.1016/j.canlet.2025.217676
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    NATURE REVIEWS DRUG DISCOVERY289181.80
    Kidney International Supplements2046.20
    Kidney International Supplements2446.20
    LANCET70087.60
    Nature Reviews Clinical Oncology127114.50
    NEW ENGLAND JOURNAL OF MEDICINE93396.40
    NATURE REVIEWS CANCER396103.80
    World Psychiatry6174.00
    World Psychiatry7074.00
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    NATURE REVIEWS MICROBIOLOGY250106.40
    NATURE REVIEWS DRUG DISCOVERY289181.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386150.90
    LANCET70087.60
    Nature Reviews Materials61105.50
    Nature Reviews Clinical Oncology127114.50
    NEW ENGLAND JOURNAL OF MEDICINE93396.40
    Nature Reviews Earth & Environment070.00
    NATURE REVIEWS CANCER396103.80
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共1456


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2025 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室